Menorrhagia
Conditions
Keywords
Menorrhagia, Lina LibrataTM, efficiency, menometrorrhagia
Brief summary
Menometrorrhagia is the first cause of consultation in gynecology. Etiology of menometrorrhagia is varied, but in majority of cases no underlying pathology is found, they are said functional idiopathic menometrorrhagia . In case of failure of medical treatment, for women who do not wish to preserve reproduction possibilities, a surgical treatment by endometrectomy (destruction of the uterine endometrial epithelial) can be proposed. Currently, a new system, Lina LibrataTM is available on the market. This system allows destructing endometrial membrane with a balloon which offer several advantages compared to present used system. Specially, it does not require dilatation of uterus's cervix and it reduces the pain. The investigator make hypothesis that the use of the system Lina LibrataTM does not cause pain and can be thus used under local anesthetic in ambulatory surgery. With the aim of developing ambulatory care, the main objective of this prospective monocentric study is to estimate the efficiency of Lina LibrataTM system in the treatment of functional idiopathic menometrorrhagia. Secondary objectives are to estimate the pain during the procedure, the rate of per and post-complications and quality of life.
Interventions
DEVICEUse of the Lina LibrataTM
Use of the Lina LibrataTM
Sponsors
Hospices Civils de Lyon
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
38 Years to 55 Years
Healthy volunteers
No
Inclusion criteria
* Women from 40 to 50 years old * Not menopausal women * Do not want pregnancy * Having dysfunctional bleeding * informed and signed consent
Exclusion criteria
* Unacceptable postoperative risk disclosed on interview: coagulation disorder, immune disorder, evolutive disease, etc * Pregnancy or wish to have later pregnancy * Endometrium cancer (or suspicious of cancer) or precancerous conditions of the endometrium * Anatomical conditions (i-e history of caesarian, transmural myomectomy) or pathological conditions (i-e long term treatment) which can weaken myometrium * Genital or urinary infection at the time of the procedure * Intra uterine device * Pelvic inflammation * Inability to understand information provided * Not covered by a national health insurance scheme, prisoner or under administrative supervision
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| rate of amenorrhea | 4 weeks |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| pain score | during surgery (Hour 0) | Pain at Hour 0 is assessed by VAS (Visual Analog Scale) rating from 0 to 10 (0=no pain). |
| recurrences of menorrhagia | at month 1 | — |
| assessment of menorrhagia on Higham's score | 1 month after surgery | Assessment by patients on Higham's score. A score greater than 100 points corresponds to bleeding greater than 80 ml of blood. |
| evolution of hemoglobinemia | 1 month after surgery | hemoglobin measured by blood test |
| per-operative complications | per surgery day 0 | — |
| post-operative complications | post surgery day 0 | — |
| measure of quality of life | at month 1 | assessed by the questionnaire SF-12 (abridged version of the Medical Outcomes Study Short-Form General Health Survey SF-36). It allows to obtain 2 scores: mental and social score (from 5.89058 to 71.966825) and physical score (from 9.94738 to 70.02246). The average of this scores in the general population is 50. |
| measure of symptoms improvement | at month 1 | assessed by the questionnaire PGI-I (from 1 "much better" to 7 "much worse") |
Countries
France
Contacts
PRINCIPAL_INVESTIGATORGéry LAMBLIN, MD
Hospices Civils de Lyon Gynaecology Department
Outcome results
None listed